Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oxytocin for Social Trust in Schizophrenia
NCT04177719Unknown
- Sponsor
- National Institute of Mental Health and Neurosciences
- Start
- Nov 2019
- Primary completion
- Apr 2022
- Modality
- Peptides
- Countries
- 1
01
Overview
Randomised, double-blind trial of oxytocin in schizophrenia (2 arms), sponsored by National Institute of Mental Health and Neurosciences. Primary endpoints: Positron Emission Tomography at 90 minutes, Functional Magnetic Resonance Imaging at 90 minutes and 1 more. Status: unknown.
02
Drugs
oxytocin
03
Conditions
schizophrenia
Beyond the preview
Go deeper on NCT04177719.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04177719.